Averna Therapeutics

Private

Watertown, MassachusettsHealthcare & Life Scienceshttps://avernatx.com/

Last Round

Series B

Mar 20, 2026

Total Funding Raised

$82M

Company Overview

Averna Therapeutics is a biotechnology company developing genomic medicines using RNA and lipid nanoparticle (LNP) technologies to durably and safely treat a broad range of diseases, including genetic diseases, cancer, and autoimmune conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

RNA therapeuticssmall molecule drug discoveryRNA-targetingbiotechnologyundruggable targetsdrug developmentstructural biologycomputational biologygenomic medicinedrug discovery platformRNA medicinebiotech startuptherapeutic pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Averna Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Averna Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Averna Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Mar 20, 2026
Series A	Jun 25, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Tal Zaks

Chairman And CEO

Executive Team

Averna Therapeutics Investors

Notable investors and investment history

Averna Therapeutics investors
Investor	Rounds
Deep Insight	Series A
Innovation Endeavors	Series A
OrbiMed	Series A, Seed
Invus Opportunities	Series A
Arc Ventures	Series A
Delos Capital Partners	Series A
Invus	Series A

View all Investors

Averna Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Averna Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Averna Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersWatertown, Massachusetts

Employee Range54

Year Founded2022

Last FundingMar 20, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.